Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19
Author(s) -
Patrick S. Fier,
Yingju Xu,
Marc Poirier,
Gilmar Brito,
Xue Zheng,
Rachel S. Bade,
E. B. Sirota,
Kevin Stone,
Lushi Tan,
Guy R. Humphrey,
Darryl Chang,
Jameson R. Bothe,
Yongqian Zhang,
Frank Bernardoni,
S. M. M. de Castro,
Michael A. Zompa,
J Taylor,
Kevin M. Sirk,
Anthony Diaz-Santana,
Ike Diribe,
Khateeta M. Emerson,
B. Krishnamurthi,
Ralph Zhao,
Michael Ward,
Chengqian Xiao,
Honggui Ouyand,
Jianfeng Zhan,
William Morris
Publication year - 2021
Publication title -
organic process research and development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 109
eISSN - 1520-586X
pISSN - 1083-6160
DOI - 10.1021/acs.oprd.1c00400
Subject(s) - covid-19 , process development , yield (engineering) , robustness (evolution) , manufacturing process , medicine , process engineering , chemistry , virology , engineering , materials science , infectious disease (medical specialty) , biochemistry , disease , outbreak , metallurgy , composite material , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom